Efficacy and safety of hangekobokuto (Banxia‐houpo‐tang) in treating panic disorder: A pilot study

Abstract

The prevalence of panic disorder in patients with comorbidities is higher than in the general population. Selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines, the common pharmacotherapy, can cause adverse effects in the patients. To research other options, we report a retrospective pilot study on hangekobokuto in treating panic disorder.